Adrenal vein sampling (AVS) is recommended for subtyping primary aldosteronism
(PA) to identify lateralized or bilateral sources of aldosterone excess,
allowing for better decision-making in regard to medical or surgical management
on a case-by-case basis. To date, no consensus exists on protocols to be used
during AVS, especially concerning sampling techniques, the timing of sampling,
and whether or not to use adrenocorticotropic hormone (ACTH) stimulation.
Interpretation criteria for selectivity, lateralization, and contralateral
suppression vary from one expert center to another, with some favoring strict
cut-offs to others being more permissive. Clinical and biochemical
post-operative outcomes can also be influenced by AVS criteria utilized to
indicate surgical therapy.In this review, we reanalyze studies on AVS highlighting the recent pathological
findings of frequent micronodular hyperplasia adjacent to a dominant
aldosteronoma (APA) overlapping with bilateral idiopathic hyperaldosteronism
(IHA) etiologies, as opposed to the less frequent unilateral single
aldosteronoma. The variable expression of melanocortin type 2 receptors in the
nodules and hyperplasia may explain the frequent discordance in lateralization
ratios between unstimulated and ACTH- stimulated samples. We conclude that
aldosterone values collected during simultaneous bilateral sampling, both at
baseline and post-ACTH stimulation, are required to adequately evaluate
selectivity, lateralization, and contralateral suppression during AVS, to better
identify all patients with PA that can benefit from a surgical indication.
Recommended cut-offs for each ratio are also presented.